Member Info for JFK8

New CSO to replace Michelle Morrow

Opened an account and closed it 20 minutes later as they dont deal AVCT shares .don't know if they do now though as it was a while ago

Trial update 👍

Buys or sells ?

30-Jan-26 16:32:47 0.0257 900,000,000 Unknown* 0.028 0.029 231.30k

30-Jan-26 16:33:10 0.0257 250,000,000 Unknown* 0.028 0.029 64.25k

15% ~ 22Million of shares in free float traded today

Ppopp . A 100 times more is £3.50 not 35p

5 x 1 mill plus 1 x 1.5 mill delayed buys just popped up

Cant get a buy quote

4 mm's on 2p or above

Significant tungsten 😄😄👍

Looks like 120 k available , 3mms moved just after you posted the 50k

0.22p

Showing as sells 0.00656

I'd expect it to go lower as its still over 500% up in a month

Dropped again to 54.3

Bids now 55

Last I heard they were looking for Lithium lol

Christina Coughlin MD, PhD, CEO of Avacta, commented:

"These data are key to support the clinical development of FAP-Exd (AVA6103) and the profile of this second pre|CISION medicine in the preclinical setting is tremendous. The sustained release mechanism developed by Avacta scientists results in a robust concentration of active drug in the tumor over five days with the disappearance from the bloodstream in only two hours. This is the exact profile needed to achieve better efficacy with this highly potent topo I inhibitor.

"Our AI collaboration has led to several key insights into the patient population for the FAP-Exd program and has helped to drive a smarter and faster clinical trial. We are eagerly anticipating the next steps for this exciting program in 2026."

6103 data announced

Best stop the interview its 15% down and dropping FFs